Skip to content

Bluestar Genomics Receives CAP Accreditation for Its Clinical Laboratory

Release Date: 13 Oct 2022 AP News - Business Wire
College of American Pathologists Logo

Bluestar Genomics, Inc., an early cancer detection company leading the development and commercialization of next-generation liquid biopsy tests focused on non-invasive detection of high-mortality cancers in high-risk patient populations, received accreditation for its clinical laboratory from the College of American Pathologists (CAP).

For the full article click here: Bluestar Genomics Receives CAP Accreditation for Its Clinical Laboratory | AP NEWS

adding all to cart
False 0
File added to media cart.